The

Dermatology CRO

Built for Sponsors

Run your Dermatology clinical trial with faster execution and higher quality

Our Dermatology CRO Executive Team

Our Dermatology CRO Executive Team has over 100 years combined experience managing dermatology clinical trials in all phases of development

Our experienced CRO executive team works closely with our expert site operations team to continuously review execution strategies, closely monitor patient recruitment efforts, and mitigate key study risks for Dermatology clinical trials.

Betsey Zbyszynski

VP, Head of Dermatology

More than 25 years in clinical research industry – 18 of those years holding strategic roles in a Dermatology CRO setting.

Janet DuBois

Medical Director, CRO

More than 20 years as a leading PI in Dermatology, has been the PI for 200+ Dermatology clinical trials across indications.

Why the Vial Dermatology CRO?

Streamlined trial startup, more predictable patient recruitment, and higher quality data.

Vial is able to leverage the abilities and resources within our site network in conjunction with our turnkey CRO capabilities, to provide our sponsors with a fully integrated service offering.

Site Network

Dermatology Clinical Trials Powered by Vial’s Fully Integrated Clinic Network

Sites
  • 80M+ Population

    within 50 miles of Vial sites

  • 35+

    Top Recruiting Sites

We have thoughtfully built our network to incorporate research experienced dermatologists who not only have a passion for new dermatology therapies, but also access to a wide range of patients.

We have thoughtfully built our network to incorporate research experienced dermatologists who not only have a passion for new dermatology therapies, but also access to a wide range of patients.

We embed our own clinical research coordinators and support staff to work side by side with highly trained PIs and Sub-Is to facilitate patient visits and deploy Vial’s optimized operational model consistently across all sites.

We embed our own dermatology clinical research coordinators and support staff to work side by side with highly trained PIs and Sub-Is to facilitate patient visits and deploy Vial’s optimized operational model consistently across all sites.

CRO Services

We Support Our Client’s Development Programs with the Following Services

vial cro
vial cro

Upon site activation, Vial’s recruitment engine goes to work, funneling patients in close geographic proximity to their site for screening and enrollment.

Lightning Fast Start-up
and Consolidated Site Activation

vial cro
vial cro

Scientific Advisory Board

Vial CRO is supported by a team of Scientific Advisors who review and provide input on the strategy and direction of the CRO in order to build the infrastructure to advance Dermatology research.

Dr. Mark Lebwohl

Waldman Professor and Chairman of the Kimberly and Eric J. Waldman Department of and Chairman of the Department of Dermatology at the Mount Sinai Hospital in New York City

Dr. David Pariser

Senior physician of Pariser Dermatology Specialist and Principal Investigator

Merola_Joseph

Associate Professor in the Department of Dermatology and Department of Medicine, Division of Rheumatology at Harvard Medical School

Jonathan Zung

Chief Development Officer at Evelo Biosciences

Our Dermatology CRO Executive Team

Our Dermatology CRO Executive
Team has over 100 years combined experience managing dermatology clinical trials in all phases
of development

Our experienced CRO executive team works closely with our expert site operations team to continuously review execution strategies, closely monitor patient recruitment efforts, and mitigate key study risks for Dermatology clinical trials.

More than 25 years in clinical research industry – 18 of those years holding strategic roles in a Dermatology CRO setting.

More than 20 years as a leading PI in Dermatology, has been the PI for 200+ Dermatology clinical trials across indications.

More than 20 years experience in the clinical research industry – holding site coordinator, monitoring and project management roles.

More than 20 years in healthcare sector, on both sponsor and CRO side of equation.

Waldman Professor and Chairman of the Kimberly and Eric J. Waldman Department of and Chairman of the Department of Dermatology at the Mount Sinai Hospital in New York City

Dr. Lebwohl is chairman emeritus of the Medical Board of the National Psoriasis Foundation. He is the founding editor of Psoriasis Forum and the Journal of Psoriasis and Psoriatic Arthritis. He has been on the editorial board of the Journal of the American Academy of Dermatology and the Journal of Skin Cancer. He is editor of the Dermatology Section of Scientific American Medicine and co-Editor-in-Chief of Skin, the Journal of Cutaneous Medicine. He has authored or co-authored over 600 publications including articles, chapters and abstracts. Dr. Lebwohl is actively involved in clinical trials of many new dermatologic treatments.

Lebwohl

Senior physician of Pariser Dermatology Specialist and Principal Investigator

Dr. Pariser is distinguished for his world-renowned expertise on psoriasis, hyperhidrosis and photodynamic therapy, a treatment for early skin cancers and pre-cancers. Throughout the span of his career, his research has led to the publication of over 300 scientific publications and 4 textbooks in medical literature.

Pariser

Associate Professor in the Department of Dermatology and Department of Medicine, Division of Rheumatology at Harvard Medical School

Dr. Merola is triple board certified in Dermatology, Internal Medicine, and Rheumatology. Dr. Merola is on the Medical Board of the National Psoriasis Foundation, the Board of the International Dermatology Outcome Measures Group, Steering Committee Member for GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis), the Board of the Lupus Foundation of America and is on the Board and Founding President of the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN). Dr. Merola is also the president-elect of the Medical Dermatology Society. He is an active PI in several Psoriasis, Atopic Dermatitis and other leading skin indications.

Merola

Our experienced CRO executive team works closely with our expert site operations team to continuously review execution strategies, closely monitor patient recruitment efforts, and mitigate key study risks.

Vial Dedicated Phase I  Unit

Vial’s Dermatology Phase 1 unit provides a unified full service solution to early clinical development.

Phase 1 Units are critical to advancing care and validating treatments, which is why it is essential to have a dependable Phase 1 unit you can rely on.


Vial’s dedicated Phase 1 research coordinators have upwards of 25 years of experience and are IATA and CPR certified. All of our research coordinators complete annual GCP and NIH training, as well as routine in-house training. In addition to extensive training, they are familiar with multiple EDS and IWRS systems, making them a well-rounded team you can trust.

500+

Dermatology Clinical Trials

10,000 +

Randomized Patients

Case Study

Recruitment Timelines Met. Guaranteed.

Trial Expectations
Goal # of Patients per site:
10 patients / site
Goal time:
>4 months
Vial Site Actuals
Vial # of Patients per site:
~35 patients / site
Recruitment time:
~1-2 months

In a Phase 3 Hyperhidrosis study,
all 3 Vial sites significantly beat the enrollment goals in a reduced time frame.

Our recruitment timelines are so predictably fast, we stand by our guarantees.

In a Phase 3 Hyperhidrosis study,
all 3 Vial sites significantly beat the enrollment goals in a reduced time frame.

Our recruitment timelines are so predictably fast, we stand by our guarantees.

Deep clinic operation integration drives higher quality data for Sponsors.

Vial's is the first CRO powered by a clinic network. Learn more about our higher quality and faster execution for your
Dermatology clinical trial.

Learn more about the Vial Site Network

Vial Technology Platform

5 Powerful Technology Solutions.
One Connected System.

eSource

Finally, paper is out, digital is in.

EDC

Speed and efficiency that sponsors love.

eTMF

Seamless file management.

ePRO

Customizable for patients in your trial.​

CTMS

Level up your trial trial operation.

Past Events

Tech-Enabled Dermatology Trials Webinar: Tech-Enabled Dermatology Clinical Trials — Delivering Faster, Higher Quality Trials for Sponsors
Join Vial CEO, Simon Burns, as he discusses tech-enabled dermatology clinical trials. In this webinar we will cover clinical technologies such as eSource, centralized monitoring, and modern patient experiences and how Vial can deliver faster, higher quality trials for sponsors.
Vial will be at the SOCS Meeting the Challenge Summit
Vial is proud to be a Friend Sponsor for the Skin of Color Society, Meeting the Challenge Summit: Diversity in Dermatology Clinical Trials. We are also proud to announce Betsey Zbyszynski as a keynote speaker on “Creating Solutions to Make Trials Less Burdensome to Physicians.”
Vial will be at the SPD 2022 47th Annual Meeting
Vial is proud to be a bronze sponsor of the Society for Pediatric Dermatology 47th Annual Meeting. If you missed us at the conference, contact us using the form below.
White Paper

Tech-Enabled Remote Monitoring Part 1

Download our white paper to learn more about each stakeholder’s benefits of tech-enabled trials.

White Paper

Tech-Enabled Remote Monitoring Part 2

Download our white paper to learn more about each stakeholder’s benefits of tech-enabled trials.

White Paper

Vial’s Deployment of Modern, Intuitive Electronic Source

Download our latest white paper to learn how utilizing eSource in clinical trials can streamline process, increase efficiency, and minimize errors.

Indications

Broad experience across Dermatology Indications and Phases

Lightning Fast Start-up and Consolidated Site Activation

vial cro
dermatology cro

Standardized Quality Across Our PIs

dermatology cro

Highly Experienced CRCs

vial cro

Contact Us

Note: If you are looking to participate in a clinical trial, please click here
Name(Required)
By submitting, you are agreeing to our terms and privacy policy
This field is for validation purposes and should be left unchanged.